These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1448790)

  • 1. The vascular plasminogen activator as source of the fibrinolytic potential observed during cardiopulmonary bypass.
    Baños G; de la Peña A; Izaguirre R
    Thromb Res; 1992 Sep; 67(5):579-88. PubMed ID: 1448790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
    Ray MJ; Marsh NA; Hawson GA
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children.
    Saatvedt K; Lindberg H; Michelsen S; Pedersen T; Geiran OR
    Scand J Clin Lab Invest; 1995 Jul; 55(4):359-67. PubMed ID: 7569739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery.
    Tanaka K; Takao M; Yada I; Yuasa H; Kusagawa M; Deguchi K
    J Cardiothorac Anesth; 1989 Apr; 3(2):181-8. PubMed ID: 2535275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.
    Aĝirbaşli MA; Song J; Lei F; Wang S; Kunselman AR; Clark JB; Myers JL; Ündar A
    Artif Organs; 2014 Jan; 38(1):28-33. PubMed ID: 24237252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
    Valen G; Eriksson E; Risberg B; Vaage J
    Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
    Eisses MJ; Seidel K; Aldea GS; Chandler WL
    Anesth Analg; 2004 May; 98(5):1208-16, table of contents. PubMed ID: 15105189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant cardiopulmonary bypass: a procoagulant state.
    Jaggers JJ; Neal MC; Smith PK; Ungerleider RM; Lawson JH
    Ann Thorac Surg; 1999 Aug; 68(2):513-20. PubMed ID: 10475421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
    Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
    Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.
    Stibbe J; Kluft C; Brommer EJ; Gomes M; de Jong DS; Nauta J
    Eur J Clin Invest; 1984 Oct; 14(5):375-82. PubMed ID: 6437836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.
    Larsson P; Alwis I; Niego B; Sashindranath M; Fogelstrand P; Wu MC; Glise L; Magnusson M; Daglas M; Bergh N; Jackson SP; Medcalf RL; Jern S
    J Thromb Haemost; 2016 Dec; 14(12):2496-2508. PubMed ID: 27706906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the plasma protease systems during open-heart surgery with dextran vs. Ringer acetate as priming solution.
    Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
    Scand J Thorac Cardiovasc Surg; 1989; 23(3):253-8. PubMed ID: 2482539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.
    Páramo JA; Rifón J; Llorens R; Casares J; Paloma MJ; Rocha E
    Haemostasis; 1991; 21(1):58-64. PubMed ID: 1907591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
    Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
    J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
    Idell S
    Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.